Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000178363 | SCV000230429 | pathogenic | not provided | 2014-11-19 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000623571 | SCV000742628 | pathogenic | Inborn genetic diseases | 2017-06-07 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000178363 | SCV005902935 | pathogenic | not provided | 2024-09-26 | criteria provided, single submitter | clinical testing | Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 28253385, 24433453, 31638560, 20700148, 20852264, 20637498, 26219881, 27480077) |
University of Washington Center for Mendelian Genomics, |
RCV000851210 | SCV000993461 | likely pathogenic | Congenital disorder of glycosylation | 2016-07-08 | no assertion criteria provided | research |